Skip to content

Study on effective dose and safety comparison of esketamine for tracheal intubation under separate anesthesia: a randomized controlled trial.

Study on effective dose and safety comparison of esketamine for tracheal intubation under separate anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035650
Enrollment
Unknown
Registered
2020-08-15
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheal intubation

Interventions

Blank:no esketamine
Group A:0.1mg/ kg esketamine (i.v.)
Group B:0.2mg/ kg esketamine (i.v.)
Group C:0.3mg/ kg esketamine (i.v.)
Group D:0.4mg/ kg ?????

Sponsors

Shandong Provincial ENT Hospital, Shandong Provincial Western Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Malampati grade I-II patients with improved difficult airway; 2. ASA grade I-II patients; 3. Patients with laryngeal obstruction grade 1 to 2; 4. Informed consent of patients.

Exclusion criteria

Exclusion criteria: 1. Patients with history of cardiopulmonary disease; 2. Patients with history of diabetes mellitus; 1. Patients with mental history or drug abuse history; 2. Patients with history of chronic pain and self-control of opioids; 3. Patients with severe cardiovascular diseases; 4. Patients with coagulation dysfunction; 5. Patients with allergic history of related drugs; 6. Patients with contraindications of intubation.

Design outcomes

Primary

MeasureTime frame
changes of hemodynamic at each time point;changes of blood sugar;OAA/S scares;satisfaction scores for the tracheal intubation process;memory scores for the tracheal intubation process;tolerability scores during tracheal intubation;tolerability scores after tracheal intubation;

Countries

China

Contacts

Public ContactJiyong Wu

Shandong Provincial ENT Hospital, Shandong Provincial Western Hospital

wujiyong521@163.com+86 13589117921

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026